Synchron Brain Implant Trials Paused After Stentrode Lead Underperforms
Synchron has voluntarily paused enrollment in second-generation Stentrode brain-computer interface trials over a lead performance problem. What we know.
Synchron has voluntarily paused enrollment in second-generation Stentrode brain-computer interface trials over a lead performance problem. What we know.
AI in neurosurgery market to grow from USD 850 million in 2025 to USD 11.3 billion by 2035 (29.5% CAGR). Growth drivers, key players and regional outlook.